OPHLF Ono Pharmaceutical Co., Ltd. — dividend yield, history & ex-dividend dates
Globally, Ono Pharmaceutical Co., Ltd., along with its affiliated entities, is engaged in the development, procurement, and commercialization of pharmaceutical products and diagnostic tools. Its product line features a wide array of therapeutic solutions, including several key oncology treatments such as OPDIVO, KYPROLIS, MEKTOVI, VELEXBRU, ADLUMIZ, and BRAFTOVI. It also offers EMEND and PROEMEND for managing chemotherapy-induced nausea and vomiting, and DEMSER for pheochromocytoma symptoms. For metabolic health, GLACTIV and FORXIGA target type 2 diabetes. The company provides medications for cardiovascular conditions (ONOACT for tachyarrhythmia, OPALMON for peripheral circulatory disorder, CORALAN for chronic heart failure) and autoimmune diseases (ORENCIA for rheumatoid arthritis). Neurological disorders are addressed with RIVASTACH for Alzheimer's and ONGENTYS for Parkinson's disease. Other significant offerings cover conditions such as overactive bladder (STAYBLA), bronchial asthma and allergic rhinitis (ONON), osteoporosis (RECALBON), and joint function improvement (JOYCLU), alongside PARSABIV for dialysis patients. Beyond its existing portfolio, the company maintains an active research and development pipeline, focusing on numerous therapeutic areas. This includes a broad spectrum of oncological conditions, such as various carcinomas (esophageal, urothelial, ovarian, bladder, prostate, hepatocellular, pancreatic, biliary tract, gastric, thyroid, colorectal, non-small cell lung), lymphomas (Hodgkin's, primary central nervous system), melanoma, acute myeloid leukemia, myelodysplastic syndrome, and virus-positive/negative solid tumors. Its developmental efforts also extend to inflammatory and autoimmune disorders like polymyositis/dermatomyositis, pemphigus, generalized scleroderma, and enthesopathy, as well as cardiovascular issues (tachyarrhythmia, thrombosis), neurodegenerative diseases, diabetic polyneuropathy, and conditions such as narcolepsy. Established in 1717, this long-standing enterprise operates from its main office in Osaka, Japan.
Dividend Snapshot
Research Scores
Scores describe this security's published financial data on a 0–100 scale using the formulas on our methodology pages. They are the same for every reader, are not a probability or a forecast, and are not a recommendation. Past dividend growth does not guarantee future increases. Report a data error.
Not Rated
How the Dividend Safety Score is built for OPHLF
| Input | Value | Points | Weight |
|---|---|---|---|
| Earnings payout ratio | Earnings payout ratio 49% (TTM to Jun 30, 2026) | 91 | 20% |
| FCF payout ratio | FCF payout ratio 29% (TTM to Jun 30, 2026) | 100 | 25% |
| Net debt / EBITDA | Net cash (TTM to Jun 30, 2026) | 100 | 15% |
| Interest coverage | Interest coverage 26.1x (TTM to Jun 30, 2026) | 100 | 10% |
| Dividend record | 37 years of uninterrupted regular payments | 98 | 20% |
| Earnings stability | Net income positive in 5 of the last 5 fiscal years (FY2022–FY2026) | 100 | 10% |
Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.
How the Dividend Growth Score is built for OPHLF
| Input | Value | Points | Weight |
|---|---|---|---|
| 5-year dividend growth | 5-year dividend CAGR 5.0% (2020–2025) | 72 | 25% |
| Consecutive annual increases | 0 consecutive annual increases (through 2025) | 10 | 20% |
| Payout headroom | Headroom from the earnings payout ratio 49% (TTM to Jun 30, 2026) | 86 | 20% |
| Earnings per share growth (3 years) | EPS CAGR -13.6% (FY2023–FY2026) | 0 | 15% |
| Revenue growth (3 years) | Revenue CAGR 5.1% (FY2023–FY2026) | 82 | 10% |
| 10-year dividend growth | 10-year dividend CAGR 6.0% (2015–2025) | 78 | 10% |
Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.
Key Metrics
Current Yield
3.59%
At the Oct 30, 2026 price
The annual dividend as a percentage of the share price. A 3% yield is about $3 of dividends a year for every $100 invested at today's price.Annualized Dividend
$0.5058
Declared May 08, 2026
The latest declared regular dividend scaled to a full year by how often it's paid (for semi-annual payers, the latest two payments), adjusted for stock splits. A $0.25 quarterly dividend annualizes to $1.00. Special dividends are excluded.Frequency
S Semi-Annual
How often the dividend is paid, read from the dates of recent payments: Q = quarterly (4x a year), M = monthly, S = semi-annual, A = annual.RSI (14)
34
As of Oct 30, 2026
Relative Strength Index (0-100), a price-momentum gauge. Above 70 is often called 'overbought', below 30 'oversold'. A technical signal, not a dividend metric.52-Week Range
$11.08 – $18.67
Closes through Oct 23, 2026
The lowest and highest price over the past year, showing where today's price sits in its recent range.Payout Ratio (TTM)
49.26%
12 months to Jun 30, 2026 (Q1 FY2027)
The share of earnings paid out as dividends over the trailing twelve months (TTM): dividends paid divided by net income across the company's four most recent reported quarters, dated by the latest quarter end. A fiscal-year tag such as FY2025 means only annual figures were available. Lower leaves more cushion; above 100% means paying out more than the company earned. It shows n/a for funds and when net income over the period was negative; for REITs and BDCs it is marked EPS-based, since they are judged on FFO/AFFO or net investment income instead.Years Paying
38
How many years of payments we have on record. This can understate very long histories where our data doesn't reach far enough back.Price / Book (TTM)
1.35
Price as of Oct 25, 2026; latest reported book value
Price-to-book ratio: the share price on the date shown divided by the latest reported book value per share. A rough valuation gauge, most useful for asset-heavy sectors like REITs, banks and insurers.S.A.F.E. Dividend Read
Quote & Key Data
Dividend Growth
How often a record like this ends in a cut
OPHLF has raised its annual dividend in 21 separate years since November 1988, which ranks 412 among the 2,430 payers with a comparable record in our dataset. In 1 year the annual total fell by more than a fifth.
Of the 878 companies we track with 10 to 24 years of increases, 661 — 75 per cent — also have at least one year in which the dividend fell by more than 20 per cent. Across every company with twenty years of comparable history, only 277 of 1078 (26 per cent) have never cut. A long record of increases is common; a record with no cut anywhere in it is not.
Measured from annual totals using split-adjusted amounts, comparing only consecutive years with the same number of payments — a stock split and a payment shifting across a year boundary both look like cuts otherwise. The current year is excluded as incomplete. How we measure a cut, and what the corrections change. Figures are for information only, not a view on any security.
Why the Yield Moved (90 Days)
OPHLF's dividend yield rose from 3.40% to 3.59% over the past ~90 days (+0.18 pp). Of that move, +0.00 pp came from changes in the dividend rate and +0.18 pp from the share price ($14.86 on Aug 03, 2026 → $14.10 on Oct 30, 2026). A yield that rises because the price fell is not an improvement in the payout itself.
Yield vs Its Own History
Across 272 daily observations over the past 13 months (through Oct 23, 2026), OPHLF's current yield is higher than approximately 61% of them. Our stored price history for OPHLF covers the past 13 months; 3- and 5-year averages are not yet computable from it and are deliberately not shown.
Adjusted Price History
Dividend History
Dividend Payment History
Ex-dividend calendar →| Amount | Type | Declared | Ex-Date | Record | Pay |
|---|---|---|---|---|---|
| $0.2544 S | Regular | May 08, 2026 | Sep 30, 2026 | Sep 30, 2026 | N/A |
| $0.2518 S | Regular | N/A | Sep 29, 2026 | Sep 30, 2026 | Sep 29, 2026 |
| $0.2514 S | Regular | May 08, 2025 | Mar 31, 2026 | Mar 31, 2026 | Jun 19, 2026 |
| $0.2703 S | Regular | May 08, 2025 | Sep 30, 2025 | Sep 30, 2025 | Dec 01, 2025 |
| $0.2668 S | Regular | May 09, 2024 | Mar 31, 2025 | Mar 31, 2025 | Jun 20, 2025 |
| $0.2792 S | Regular | May 09, 2024 | Sep 30, 2024 | Sep 30, 2024 | Dec 02, 2024 |
| $0.2643 S | Regular | May 10, 2023 | Mar 28, 2024 | Mar 31, 2024 | Jun 21, 2024 |
| $0.2677 S | Regular | May 10, 2023 | Sep 28, 2023 | Sep 30, 2023 | Dec 01, 2023 |
| $0.2788 S | Regular | May 11, 2022 | Mar 30, 2023 | Mar 31, 2023 | Jun 23, 2023 |
| $0.2285 S | Regular | May 11, 2022 | Sep 29, 2022 | Sep 30, 2022 | Dec 01, 2022 |
| $0.2296 S | Regular | May 11, 2021 | Mar 30, 2022 | Mar 31, 2022 | Jun 24, 2022 |
| $0.2504 S | Regular | May 11, 2021 | Sep 29, 2021 | Sep 30, 2021 | Dec 01, 2021 |
| $0.2496 S | Regular | May 12, 2020 | Mar 30, 2021 | Mar 31, 2021 | Jun 18, 2021 |
| $0.2129 S | Regular | May 12, 2020 | Sep 29, 2020 | Sep 30, 2020 | Dec 01, 2020 |
| $0.2082 S | Regular | May 09, 2019 | Mar 30, 2020 | Mar 31, 2020 | Jun 19, 2020 |
| $0.2082 S | Regular | May 09, 2019 | Sep 27, 2019 | Sep 30, 2019 | Dec 02, 2019 |
| $0.2038 S | Regular | N/A | Mar 27, 2019 | Mar 31, 2019 | Jun 21, 2019 |
| $0.1992 S | Regular | N/A | Sep 26, 2018 | Sep 30, 2018 | Dec 03, 2018 |
| $0.1882 S | Regular | N/A | Mar 28, 2018 | Mar 31, 2018 | Jun 25, 2018 |
| $0.2217 S | Regular | N/A | Sep 27, 2017 | Sep 30, 2017 | Dec 01, 2017 |
| $0.1801 S | Regular | N/A | Mar 29, 2017 | Mar 31, 2017 | Jun 30, 2017 |
| $0.1989 S | Regular | N/A | Sep 28, 2016 | Sep 30, 2016 | Dec 01, 2016 |
| $0.7941 S | Regular | N/A | Mar 29, 2016 | Mar 31, 2016 | Jun 30, 2016 |
| $0.7510 S | Regular | N/A | Sep 28, 2015 | Sep 30, 2015 | Dec 01, 2015 |
| $0.7553 S | Regular | N/A | Mar 27, 2015 | Mar 31, 2015 | Jun 29, 2015 |
| $0.8233 S | Regular | N/A | Sep 26, 2014 | Sep 30, 2014 | Dec 01, 2014 |
| $0.8813 S | Regular | N/A | Mar 27, 2014 | Mar 31, 2014 | Jun 30, 2014 |
| $0.9095 S | Regular | N/A | Sep 26, 2013 | Sep 30, 2013 | Dec 02, 2013 |
| $0.9536 S | Regular | N/A | Mar 27, 2013 | Mar 31, 2013 | Jun 27, 2013 |
| $1.1571 S | Regular | N/A | Sep 26, 2012 | Sep 30, 2012 | Dec 03, 2012 |
| $1.0877 S | Regular | N/A | Mar 28, 2012 | Mar 31, 2012 | Jun 29, 2012 |
| $1.1763 S | Regular | N/A | Sep 28, 2011 | Sep 30, 2011 | Dec 01, 2011 |
| $1.0924 S | Regular | N/A | Mar 29, 2011 | Mar 31, 2011 | Jun 30, 2011 |
| $1.0737 S | Regular | N/A | Sep 28, 2010 | Sep 30, 2010 | Dec 01, 2010 |
| $0.9713 S | Regular | N/A | Mar 29, 2010 | Mar 31, 2010 | Jun 30, 2010 |
| $1.0018 S | Regular | N/A | Sep 25, 2009 | Sep 30, 2009 | Dec 01, 2009 |
| $0.9107 S | Regular | N/A | Mar 26, 2009 | Mar 31, 2009 | Jun 29, 2009 |
| $0.8464 S | Regular | N/A | Sep 25, 2008 | Sep 30, 2008 | Dec 01, 2008 |
| $1.1316 S | Regular | N/A | Mar 26, 2008 | Mar 31, 2008 | Jun 30, 2008 |
| $0.7848 S | Regular | N/A | Sep 25, 2007 | Sep 30, 2007 | Dec 03, 2007 |
| $0.5082 S | Regular | N/A | Mar 27, 2007 | Mar 31, 2007 | Jun 29, 2007 |
| $0.6851 A | Regular | N/A | Mar 28, 2006 | Mar 31, 2006 | Jun 30, 2006 |
| $0.6077 A | Regular | N/A | Mar 28, 2005 | Mar 31, 2005 | Jun 30, 2005 |
| $0.4238 A | Regular | N/A | Mar 26, 2004 | Mar 31, 2004 | Jun 30, 2004 |
| $0.3329 A | Regular | N/A | Mar 26, 2003 | Mar 31, 2003 | Jun 30, 2003 |
| $0.2549 A | Regular | N/A | Mar 26, 2002 | Mar 31, 2002 | Jun 28, 2002 |
| $0.2771 A | Regular | N/A | Mar 27, 2001 | Mar 31, 2001 | Jun 29, 2001 |
| $0.3186 A | Regular | N/A | Mar 28, 2000 | Mar 31, 2000 | Jun 30, 2000 |
| $30.0000 A | Regular | N/A | Mar 26, 1999 | Mar 31, 1999 | Jun 30, 1999 |
| $28.0000 A | Regular | N/A | Mar 26, 1998 | Mar 31, 1998 | Jun 29, 1998 |
| $28.0000 A | Regular | N/A | Mar 26, 1997 | Mar 31, 1997 | Jun 30, 1997 |
| $28.0000 A | Regular | N/A | Mar 26, 1996 | Mar 31, 1996 | Jun 28, 1996 |
| $27.0000 A | Regular | N/A | Mar 28, 1995 | Mar 31, 1995 | Jun 30, 1995 |
| $25.0000 A | Regular | N/A | Mar 28, 1994 | Mar 31, 1994 | Jun 30, 1994 |
| $20.0000 A | Regular | N/A | Mar 26, 1993 | Mar 31, 1993 | Jun 30, 1993 |
| $14.0000 A | Regular | N/A | Mar 26, 1992 | Mar 31, 1992 | Jun 29, 1992 |
| $13.5000 A | Regular | N/A | Mar 26, 1991 | Mar 31, 1991 | Jun 28, 1991 |
| $4.0000 A | Special | N/A | Mar 27, 1990 | Mar 31, 1990 | Jun 29, 1990 |
| $12.0000 A | Regular | N/A | Nov 27, 1989 | Nov 30, 1989 | Feb 28, 1990 |
| $12.0000 A | Regular | N/A | Nov 26, 1988 | N/A | Mar 16, 1989 |
1 future payment listed by our data provider without a declaration is a projection, so it is not listed here or shown as a last or next dividend.
Peer Comparison
Selected Drug Manufacturers - General dividend payers we cover, strongest DividendRank first — for context, not a recommendation.
| Ticker | Name | Yield | 5-Yr Growth | Streak | Rank |
|---|---|---|---|---|---|
| ZTS | Zoetis Inc. | 2.69% | 20.1% | 11 yrs | 94 |
| BMY | Bristol-Myers Squibb Company | 4.10% | 6.6% | 18 yrs | 86 |
| ALPMY | Astellas Pharma Inc. | 3.10% | 5.6% | 11 yrs | 80 |
| ALPMF | Astellas Pharma Inc. | 2.87% | 5.9% | 3 yrs | 80 |
Related Guides & Lists
OPHLF dividend — frequently asked questions
Does Ono Pharmaceutical Co., Ltd. pay a dividend?
Yes. Ono Pharmaceutical Co., Ltd. (OPHLF) currently pays a dividend. The annualized dividend is about $0.51 per share, a yield of approximately 3.59%.
What is Ono Pharmaceutical Co., Ltd.'s dividend yield?
Ono Pharmaceutical Co., Ltd.'s dividend yield is approximately 3.59%, based on the most recent regular payment annualized against the current share price. Yields move as the share price changes.
How often does Ono Pharmaceutical Co., Ltd. pay dividends?
Ono Pharmaceutical Co., Ltd. pays dividends semi-annually — 2 times per year.
How long has Ono Pharmaceutical Co., Ltd. paid dividends?
Ono Pharmaceutical Co., Ltd. has 38 years of dividend payments on record.
Data updated Oct 30, 2026. This research page is generated from Dividendly's structured market and dividend dataset using the approach described on our methodology and data sources pages. Data is automatically validated using defined rules and may also be periodically reviewed. Research only, not investment advice. Spotted a data error? Report it.